Interleukin-4 signaling in B lymphocytes from patients with X-linked severe combined immunodeficiency

J Biol Chem. 1997 Mar 14;272(11):7314-9. doi: 10.1074/jbc.272.11.7314.

Abstract

Interleukin-4 (IL-4) is an important cytokine for B and T lymphocyte function and mediates its effects via a receptor that contains gammac. B cells derived from patients with X-linked severe combined immunodeficiency (X-SCID) are deficient in gammac and provide a useful model in which to dissect the role of this subunit in IL-4-mediated signaling. We found that although IL-4 stimulation of X-SCID B cells did not result in Janus tyrosine kinase-3 (JAK3) phosphorylation, other IL-4 substrates including JAK1 and IRS-1 were phosphorylated. Additionally, we detected signal transducers and activators of transcription 6 (STAT6) tyrosine phosphorylation and DNA binding activity in X-SCID B cells with a wide range of gammac mutations. However, reconstitution of these X-SCID B cells with gammac enhanced IL-4-mediated responses including STAT6 phosphorylation and DNA binding activity and resulted in increased CD23 expression. Thus, gammac is not necessary to trigger IL-4-mediated responses in B cells, but its presence is important for optimal IL-4-signaling. These results suggest that two distinct IL-4 signaling pathways exist.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • B-Lymphocytes / immunology*
  • B-Lymphocytes / metabolism
  • Cells, Cultured
  • Humans
  • Interleukin-4 / immunology*
  • Interleukin-4 / metabolism
  • Male
  • Molecular Sequence Data
  • STAT6 Transcription Factor
  • Severe Combined Immunodeficiency / immunology*
  • Signal Transduction*
  • Trans-Activators / metabolism*

Substances

  • STAT6 Transcription Factor
  • STAT6 protein, human
  • Trans-Activators
  • Interleukin-4

Associated data

  • GENBANK/A25071